Global Single-Use Bioreactors Market Size study, by Product (System, 2D, 3D Media Bag, Filtration Assemblies), by Molecule (mAbs, Vaccine), by Cell type (Mammalian, Bacteria), by Application (R&D, Process Development), by End User (Biopharma, CROs & CMOs)

Global Single-Use Bioreactors Market Size study, by Product (System, 2D, 3D Media Bag, Filtration Assemblies), by Molecule (mAbs, Vaccine), by Cell type (Mammalian, Bacteria), by Application (R&D, Process Development), by End User (Biopharma, CROs & CMOs), and Regional Forecasts 2021-2027.

Global Single-Use Bioreactors Market is valued approximately at USD 2.81 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 21.1% over the forecast period 2021-2027. Easy process for the cultivation of marine organisms and growing adoption of single-use bioreactors among small companies are the factors which are driving the growth of Single-Use Bioreactors market. Furthermore, increasing research and development in biopharmaceuticals will be anticipating the growth of market in forecasted period. For instance: In 2020, Sartorius Stedim Biotech, a key market player, introduced BIOSTAT STR Generation 3 Single-Use Bioreactor. However, regulatory concerns related to SUBs may impede market growth over the forecast period of 2021-2027.

Global Single-Use Bioreactors market analysis on basis of region includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is a significant region across the world in terms of market share due to presence of major key market players in the region. Whereas Asia Pacific is anticipated to exhibit the highest growth rate over the forecast period 2021-2027 due to the presence of established biopharmaceutical industry in the region.
Major market player included in this report are:
Sartorius Stedim Biotech
Thermo Fisher Scientific
Danaher Corporation
Merck KGaA
Getinge AB
Eppendorf AG
CESCO Bioengineering
Cellexus
PBS Biotech Inc.
Distek Inc.


The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
Single-use Bioreactor Systems
Single-use Media Bags
Single-use Filtration Assemblies
Other Products
By Type:
Stirred-tank SUBs
Wave-induced SUBs
Bubble-column SUBs
Other SUBs
By Cell type:
Mammalian Cells
Bacterial Cells
Yeast Cells
Other Cells (Insect and plant cells)
By Molecule Type:
Monoclonal Antibodies
Vaccines
Gene-modified cells
Stem Cells
Other Molecules
By Application:
Research and Development (R&D)
Process Development
Bioproduction
BY End-User:
Pharmaceutical & Biopharmaceutical Companies
CROs & CMOs
Academic & Research Institutes

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019
Base year – 2020
Forecast period – 2021 to 2027.

Target Audience of the Global Single-Use Bioreactors Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

Companies Mentioned

Sartorius Stedim Biotech
Thermo Fisher Scientific
Danaher Corporation
Merck KGaA
Getinge AB
Eppendorf AG
CESCO Bioengineering
Cellexus
PBS Biotech Inc.
Distek Inc.